1-(3,4-dimethoxybenzyl)-N-hydroxy-4-oxo-1,4-dihydroquinoline-3-carboxamide

ID: ALA4646322

Chembl Id: CHEMBL4646322

PubChem CID: 156019335

Max Phase: Preclinical

Molecular Formula: C19H18N2O5

Molecular Weight: 354.36

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc(Cn2cc(C(=O)NO)c(=O)c3ccccc32)cc1OC

Standard InChI:  InChI=1S/C19H18N2O5/c1-25-16-8-7-12(9-17(16)26-2)10-21-11-14(19(23)20-24)18(22)13-5-3-4-6-15(13)21/h3-9,11,24H,10H2,1-2H3,(H,20,23)

Standard InChI Key:  ZGGAALVMIBGIER-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4646322

    ---

Associated Targets(non-human)

Akr1b1 Aldose reductase (4007 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Akr1a1 Aldehyde reductase (126 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 354.36Molecular Weight (Monoisotopic): 354.1216AlogP: 2.19#Rotatable Bonds: 5
Polar Surface Area: 89.79Molecular Species: NEUTRALHBA: 6HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 8.93CX Basic pKa: 0.10CX LogP: 1.97CX LogD: 1.96
Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.54Np Likeness Score: -0.86

References

1. Han Z, Zhu J, Zhang Y, Zhang Y, Zhang H, Qi G, Zhu C, Hao X..  (2020)  Novel quinolin-4(1H)-one derivatives as multi-effective aldose reductase inhibitors for treatment of diabetic complications: Synthesis, biological evaluation, and molecular modeling studies.,  30  (9): [PMID:32192796] [10.1016/j.bmcl.2020.127101]

Source